FDA Recommended Heartburn Drugs May Cause Kidney Failure and Osteoperosis

It appears that most drugs like Zantac, Prilosec, and others have severe side effects greater than the benefits of reducing stomach discomfort

Tuesday, May 5, 2020 - When the US Food and Drug Administration (FDA) banned Zantac last month from sales in the United States the agency was quick to point out that heartburn sufferers need not quit heartburn medications cold-turkey but should consider switching antacid brands to one that has not tested positive for NDMA, the carcinogen that is allegedly causing all types of gastrointestinal, stomach and bladder cancer. The FDA may be changing their tune about recommending non-NDMA brands Nexium, Prevacid, and the best-selling Prilosec, however, now that close to 15,000 lawsuits have been filed that accuse the over-the-counter medication of causing kidney failure, osteoporosis, and other serious health problems. Prilosec has been on the FDA's list of heartburn medications to switch to for those that are unable to get Zantac because of the FDA ban and company recall. Zantac users that have developed stomach, bladder, esophageal, gastrointestinal, prostate and other types of cancer have consulted a Zantac cancer attorney for a free consultation to see if they qualify to file a claim against Sanofi, the maker of the medication. Nexium, Prilosec, and Prevacid are also considered a proton pump inhibitor (PPI) medications that prevent the stomach from producing acid.

In lawsuits filed by Zantac cancer lawyers, plaintiffs allege that PPI drug manufacturers were negligent in failing to warn consumers of kidney failure and bone density weakening the side effects of their drugs. "Each of the claims raises similar allegations that users and the medical community were not adequately warned the widely used heartburn medications may increase the risk of chronic kidney disease, acute kidney injury, kidney failure, and other side effects," according to the online publication. Because of the similarities in the scientific allegations these and future lawsuits have been consolidated before U.S. District Judge Claire C. Cecchi in the U.S. District Court for the District of New Jersey in multidistrict litigation (MDL). MDL is not the same as a class action lawsuits as each case is treated individually but certain pre-trial procedures such as discovery are common to all, unclogging the courts of repetitive procedures. According to About Lawsuits plaintiffs are focusing on prior studies that indicated that PPI drugs may cause additional health risks that have not been addressed by the manufacturers in the form of a product warning: AL writes: "a study published in April 2016, in which researchers with the Department of Veterans Affairs found that users of Nexium, Prilosec or other PPIs may be 96% more likely to develop kidney failure and 28% more likely to develop chronic kidney disease after five years of use." Kidney damage is especially deadly as studies show that it develops silently along with high blood pressure until the damage has occurred and it is too late. Heartburn sufferers are encouraged to make definitive lifestyle changes such as quitting smoking or drinking alcohol and coffee, eating a plant-based diet, exercising more, and trying to reduce stress at work and home with meditation and long walks.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.